Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: Results of a multicentre retrospective study

European Journal of Surgical Oncology

Volumn 39, Issue 3, 2013, Pages 235-241

  Honore C ^a   Goere D ^a   Messager, M ^b   Souadka, A ^a   Dumont, F ^a   Piessen, G ^b   Elias, D ^a   Mariette, C ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Gastric cancer; Multicentre study; Peritoneal carcinomatosis; Signet ring cell adenocarcinoma; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CHEMORADIOTHERAPY; ESO GASTRIC SIGNET RING CELL ADENOCARCINOMA; FEMALE; GASTRECTOMY; HEALTH SURVEY; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; STOMACH ADENOCARCINOMA; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SIGNET RING CELL; ESOPHAGEAL NEOPLASMS; FEMALE; FRANCE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84874113348     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.12.013     Document Type: Article

References (34)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
2. G. Piessen, M. Messager, E. Leteurtre, J.P. Triboulet, and C. Mariette Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation Ann Surg 250 2009 878 887
3. H. Wu, J.A. Rusiecki, K. Zhu, J. Potter, and S.S. Devesa Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site Cancer Epidemiol Biomarkers Prev 18 2009 1945 1952
4. S.R. Alberts, A. Cervantes, and C.J. van de Velde Gastric cancer: epidemiology, pathology and treatment Ann Oncol 14 Suppl. 2 2003 ii31 ii36
5. H. Watanabe, J.R. Jass, and L.H. Sobin Histological typing of esophageal and gastric tumors 2nd ed. WHO international classification of tumors 1990 Springer-Verlag Berlin
6. M. Zhang, G. Zhu, H. Zhang, H. Gao, and Y. Xue Clinicopathologic features of gastric carcinoma with signet ring cell histology J Gastrointest Surg 14 2010 601 606
7. C.H. Yoo, S.H. Noh, D.W. Shin, S.H. Choi, and J.S. Min Recurrence following curative resection for gastric carcinoma Br J Surg 87 2000 236 242
8. F. Roviello, D. Marrelli, G. de Manzoni, P. Morgagni, A. Di Leo, L. Saragoni Italian Research Group for Gastric Cancer Prospective study of peritoneal recurrence after curative surgery for gastric cancer Br J Surg 90 2003 1113 1119
9. B. Sakar, H. Karagol, and M. Gumus Timing of death from tumor recurrence after curative gastrectomy for gastric cancer Am J Clin Oncol 27 2004 205 209
10. O. Glehen, F.N. Gilly, C. Arvieux Association Française de Chirurgie Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy Ann Surg Oncol 17 2010 2370 2377
11. X.J. Yang, Y. Li, and A.H. Al-shammaa Hassan Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases Ann Surg Oncol 16 2009 345 351
12. C. Dromain, S. Leboulleux, and A. Auperin Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT Abdom Imaging 33 2008 87 93
13. T.D. Yan, D. Black, and P.H. Sugarbaker A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer Ann Surg Oncol 14 2007 2702 2713
14. S.Y. Wang, C.N. Yeh, and H.L. Lee Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy Ann Surg Oncol 16 2009 2738 2743
15. C. Mariette, G. Piessen, N. Briez, C. Gronnier, and J.P. Triboulet Oesophagogastric junction adenocarcinoma: which therapeutic approach? Lancet Oncol 12 2011 296 305
16. S. Moriguchi, Y. Maehara, and D. Korenaga Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer Surg Oncol 1 1992 341 346
17. Y. Maehara, S. Hasuda, T. Koga, E. Tokunaga, Y. Kakeji, and K. Sugimachi Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer Br J Surg 87 2000 353 357
18. M. D'Angelica, M. Gonen, M.F. Brennan, A.D. Turnbull, M. Bains, and M.S. Karpeh Patterns of initial recurrence in completely resected gastric adenocarcinoma Ann Surg 240 2004 808 816
19. T. Kamei, J. Kitayama, H. Yamashita, and H. Nagawa Intraoperative blood loss is a critical risk factor for peritoneal recurrence after curative resection of advanced gastric cancer World J Surg 33 2009 1240 1246
20. Y. Ikeda, M. Mori, T. Kamakura, M. Saku, and K. Sugimachi Immunohistochemical expression of sialyl Tn and sialyl Lewis(a) antigens in stromal tissue correlates with peritoneal dissemination in stage IV human gastric cancer Eur J Surg Oncol 21 1995 168 175
21. M.F. Fanelli, M.J. Silva, and T.F. de Paiva Jr. Factors correlated with peritoneal carcinomatosis and survival in patients with gastric cancer treated at a single institution in Brazil Int J Clin Oncol 14 2009 326 331
22. B. Sadeghi, C. Arvieux, and O. Glehen Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study Cancer 88 2000 358 363
23. K. Hanazaki, Y. Mochizuki, and T. Machida Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer Hepatogastroenterology 46 1999 1238 1243
24. K. Inoue, Y. Nakane, and T. Michiura Feasibility and accuracy of second-look laparoscopy after gastrectomy for gastric cancer Surg Endosc 23 2009 2307 2313
25. D. Cunningham, W.H. Allum, S.P. Stenning MAGIC Trial Participants Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 2006 11 20
26. M. Ychou, V. Boige, and J.P. Pignon Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial J Clin Oncol 29 2011 1715 1721
27. M. Messager, J.H. Lefevre, V. Pichot-Delahaye, A. Souadka, G. Piessen, C. Mariette FREGAT Working Group-FRENCH The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study Ann Surg 254 2011 684 693
28. C. Shi, B. Yang, Q. Chen, J. Yang, and N. Fan Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer Oncology 80 2011 289 295
29. S. Scaringi, R. Kianmanesh, and J.M. Sabate Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience Eur J Surg Oncol 34 2008 1246 1252
30. A. De Roover, B. Detroz, and O. Detry Adjuvant hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) associated with curative surgery for locally advanced gastric carcinoma. An initial experience Acta Chir Belg 106 2006 297 301
31. P.A. Leake, R. Cardoso, and R. Seevaratnam A systematic review of the accuracy and utility of peritoneal cytology in patients with gastric cancer Gastric Cancer 2011 Aug 2 Epub ahead of print [accessed 28.07.12]
32. A.F. Okines, and D. Cunningham Multimodality treatment for localized gastro-oesophageal cancer Ann Oncol 21 Suppl. 7 2010 vii286 vii293
33. Fédération Francophone de Cancérologie Digestive. Guidelines in digestive oncology. Available: http://www.ffcd.fr [accessed 28.07.12] [article in French].
34. G. de Manzoni, G. Verlato, and A. Di Leo Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer World J Surg 30 2006 579 584